WHO. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843.
[2]
Kanis, J.A., et al. (2013). Diagnosis of osteoporosis and fracture threshold. Osteoporosis International.
[3]
Compston, J.E., et al. (2019). Corrigendum to: 'European guidance for the diagnosis and management of osteoporosis in postmenopausal women'. Osteoporosis International.
[4]
Eastell, R., et al. (2019). Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism.
[5]
Kanis, J.A., et al. (2021). A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporosis International.
[6]
Kanis, J.A., et al. (2019). Executive summary of the 2019 ISCD Official Position on bone densitometry. Journal of Clinical Densitometry.
[7]
中华骨质疏松和骨矿盐疾病杂志. (2020). Osteoporosis and other bone diseases guidelines.